LACK OF EFFECT OF IMPROVED GLYCEMIC CONTROL ON C-PEPTIDE SECRETION IN PATIENTS WITHOUT RESIDUAL B-CELL FUNCTION

被引:5
作者
SEIGLER, DE [1 ]
REEVES, ML [1 ]
SKYLER, JS [1 ]
机构
[1] UNIV MIAMI,SCH MED,DIABET METAB UNIT,MIAMI,FL 33101
关键词
D O I
10.2337/diacare.5.3.334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:334 / 336
页数:3
相关论文
共 50 条
[31]   CHARACTERIZATION OF RESIDUAL BETA-CELL FUNCTION IN DIABETICS BY A NEW C-PEPTIDE RADIOIMMUNOASSAY [J].
BEISCHER, W ;
RAPTIS, S ;
KELLER, L ;
HEINZE, E ;
SCHRODER, KE ;
PFEIFFER, EF .
DIABETOLOGIA, 1975, 11 (04) :332-332
[32]   Alpha-Cell Function in Patients with Type 1 Diabetes Is Compromised with Different Levels of Residual C-Peptide [J].
Zhang, Lingyu ;
Shi, Yuwen ;
Huang, Yiting ;
Hu, Qizhen ;
Qin, Yao ;
Zhang, Mei .
DIABETES, 2020, 69
[33]   Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial [J].
Ware, Julia ;
Boughton, Charlotte K. ;
Allen, Janet M. ;
Wilinska, Malgorzata E. ;
Hartnell, Sara ;
Thankamony, Ajay ;
Randell, Tabitha ;
Ghatak, Atrayee ;
Besser, Rachel E. J. ;
Elleri, Daniela ;
Trevelyan, Nicola ;
Campbell, Fiona M. ;
Sibayan, Judy ;
Bailey, Ryan ;
Calhoun, Peter ;
Dunseath, Gareth ;
Hovorka, Roman .
DIABETES CARE, 2024, 47 (08) :1441-1448
[34]   With or Without Residual C-Peptide, Patients with Type 2 Diabetes Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring [J].
Bailey, Ryan ;
Calhoun, Peter ;
Chao, Christy ;
Walker, Tomas C. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (04) :281-284
[35]   HOME BLOOD-GLUCOSE MONITORING, GLYCOSYLATED HEMOGLOBIN AND FRUCTOSAMINE - THEIR RELATIONSHIPS IN DIABETIC-PATIENTS WITH AND WITHOUT RESIDUAL C-PEPTIDE SECRETION [J].
BRICHARD, SM ;
VANDENABBEELE, E ;
KETELSLEGERS, JM ;
LAMBERT, AE .
DIABETES & METABOLISM, 1989, 15 (06) :388-393
[36]   Effect of 24 months of optimised glucose control on residual C-peptide secretion in youth with new onset type 1 diabetes [J].
Ware, J. ;
Boughton, C. K. ;
Allen, J. M. ;
Wilinska, M. E. ;
Thankamony, A. ;
Randell, T. ;
Ghatak, A. ;
Besser, R. E. J. ;
Elleri, D. ;
Trevelyan, N. ;
Campbell, F. M. ;
Bailey, R. ;
Dunseath, G. ;
Hovorka, R. .
DIABETOLOGIA, 2022, 65 (SUPPL 1) :S361-S361
[37]   LACK OF METABOLIC EFFECT OF C-PEPTIDE IN NORMAL SUBJECTS AND JUVENILE DIABETIC-PATIENTS [J].
HAGEN, C ;
FABER, OK ;
BINDER, C ;
ALBERTI, KGMM .
ACTA ENDOCRINOLOGICA, 1977, 85 :29-29
[38]   Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion [J].
McKillop, A. M. ;
Ng, M. T. ;
Abdel-Wahab, Y. H. A. ;
Flatt, P. R. .
DIABETES OBESITY & METABOLISM, 2014, 16 (10) :937-946
[39]   Influence of residual C-peptide secretion on nocturnal serum TSH peak in well-controlled diabetic patients [J].
Coiro, V ;
Volpi, R ;
Marchesi, C ;
Capretti, L ;
Speroni, G ;
Caffarri, G ;
Chiodera, P .
CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :305-310
[40]   C-PEPTIDE RESPONSE TO GLUCAGON - TEST FOR RESIDUAL BETA-CELL FUNCTION IN DIABETES-MELLITUS [J].
FABER, OK ;
BINDER, C .
DIABETES, 1977, 26 (07) :605-610